EnerisantEnerisant (INN; developmental code name TS-091) is an experimental drug under investigation as a potential treatment for narcolepsy. It is a member of the histamine H3 receptor antagonist/inverse agonist class of medications. Read from the Drugbox of the Wikipedia article Enerisant, revision 1328705051.

Property

Value

Formula

C22H30N4O3, 398.51 g/mol

Protein binding

31.35 %

Elimination half-life

8 h

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.